Amyloid-beta oligomers increase the localization of prion protein at the cell surface

Fabiana A Caetano1, Flavio H Beraldo, Glaucia N M Hajj

  • 1J. Allyn Taylor Centre for Cell Biology, Robarts Research Institute, University of Western Ontario, London, Ontario, Canada.

Insights

Alzheimer's disease amyloid-β oligomers signal through the prion protein (PrP(C)), increasing its cell surface presence. This study reveals PrP(C) as a key player in Aβ-induced cellular dysfunction.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Alzheimer's disease involves amyloid-β (Aβ) peptide interactions at the cell surface, disrupting synaptic function.
  • The prion protein (PrP(C)) is a potential receptor for Aβ, mediating its cellular effects.
  • Understanding Aβ-PrP(C) interactions is crucial for elucidating Alzheimer's pathogenesis.

Purpose of the Study:

  • To investigate the role of PrP(C) as a receptor for Aβ oligomers.
  • To determine if Aβ oligomers signal through PrP(C) in a dependent manner.
  • To explore the effects of Aβ oligomers on PrP(C) trafficking and localization.

Main Methods:

  • Immunofluorescence and flow cytometry to assess PrP(C) localization.
  • Cell surface protein biotinylation to quantify cell surface PrP(C).
  • Live cell confocal and total internal reflection microscopy to study PrP(C) dynamics.

Main Results:

  • Aβ oligomers, but not monomers, increased cell surface localization of PrP(C) in cell lines and neuronal cultures.
  • Aβ oligomers inhibited the endocytosis of PrP(C).
  • Aβ oligomers promoted the clustering of PrP(C) at the cell surface.

Conclusions:

  • Aβ oligomers signal in a PrP(C)-dependent manner, supporting PrP(C)'s role as a receptor.
  • Aβ oligomers alter PrP(C) trafficking, leading to increased cell surface accumulation.
  • These findings provide new insights into the molecular mechanisms of Alzheimer's disease progression.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...